论文信息 - Efficacy and safety of once-weekly semaglutide vs exenatide ER after 56 Weeks in subjects with type 2 diabetes (SUSTAIN 3) - 字舞流文

Efficacy and safety of once-weekly semaglutide vs exenatide ER after 56 Weeks in subjects with type 2 diabetes (SUSTAIN 3)

G. Charpentier | A. Ahmann | V. Aroda | A. Holst | I. Lingvay | F. Dotta | M. Capehorn | E. Henkel | M. Annett